Litigation Details for TEVA PHARMACEUTICALS USA, INC. v. UNITED STATES FOOD AND DRUG ADMINISTRATION (D.D.C. 2020)
✉ Email this page to a colleague
TEVA PHARMACEUTICALS USA, INC. v. UNITED STATES FOOD AND DRUG ADMINISTRATION (D.D.C. 2020)
Docket | ⤷ Try a Trial | Date Filed | 2020-03-24 |
Court | District Court, District of Columbia | Date Terminated | 2020-12-30 |
Cause | 05:0706 Judicial Review of Agency Actions | Assigned To | Beryl Alaine Howell |
Jury Demand | None | Referred To | |
Patents | 9,402,874 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in TEVA PHARMACEUTICALS USA, INC. v. UNITED STATES FOOD AND DRUG ADMINISTRATION
Details for TEVA PHARMACEUTICALS USA, INC. v. UNITED STATES FOOD AND DRUG ADMINISTRATION (D.D.C. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-12-30 | 54 | Memorandum & Opinion | treatment using” Copaxone, U.S. Patent No. 9,402,874 (“’874 Patent”). Decl. of Colman Ragan ¶ 6 (“Ragan Decl…claimed in a patent or the use of which is claimed in a patent before the expiration of such patent.” 35 U.…and ’993 Patents, as process patents, were never listed in the Orange Book; the ’874 Patent was listed…allow patent holders to bring preapproval patent infringement suits to enforce process patents. Fed. ….gov/ media/71474/download. “Process patents” (that is, patents claiming methods of manufacturing or | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |